Thrivent Financial for Lutherans Has $2.30 Million Position in Healthpeak Properties, Inc. $DOC

Thrivent Financial for Lutherans boosted its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 126.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 143,123 shares of the real estate investment trust’s stock after purchasing an additional 79,828 shares during the period. Thrivent Financial for Lutherans’ holdings in Healthpeak Properties were worth $2,301,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Argent Advisors Inc. bought a new stake in Healthpeak Properties in the third quarter valued at about $1,536,000. Twin City Private Wealth LLC bought a new stake in Healthpeak Properties in the third quarter valued at about $1,148,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Healthpeak Properties by 7.0% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust’s stock valued at $37,063,000 after acquiring an additional 126,322 shares during the period. JPMorgan Chase & Co. increased its stake in Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after acquiring an additional 8,212,504 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in Healthpeak Properties by 8.4% in the third quarter. Bank of New York Mellon Corp now owns 6,754,147 shares of the real estate investment trust’s stock valued at $129,342,000 after acquiring an additional 525,875 shares during the period. Institutional investors own 93.57% of the company’s stock.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.23% of the company’s stock.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $19.74 on Tuesday. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $13.61 billion, a price-to-earnings ratio of 61.68, a P/E/G ratio of 2.51 and a beta of 1.00. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $19.91. The firm’s 50-day moving average price is $17.55 and its two-hundred day moving average price is $17.27.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, equities analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

Wall Street Analyst Weigh In

DOC has been the topic of a number of analyst reports. UBS Group upped their target price on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Morgan Stanley upped their target price on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday. Royal Bank Of Canada upped their target price on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Finally, Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Five analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and an average target price of $19.08.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.